Tag:

BioSante

Latest Headlines

Latest Headlines

Cell-based pancreatic cancer vaccine increases survival

March 1, 2012 | By
BioSante Pharmaceuticals' ($BPAX) shares rose 14% on the news its pancreatic cancer vaccine increased survival by around 60%.

Orelli: BioSante melanoma deal could be better

July 28, 2011 | By
Motley Fool's Brian Orelli weighed in on BioSante Pharmaceuticals' $100,000 upfront deal with the John P. Hussman Foundation for melanoma vaccine development, saying he considered the deal less than

Aduro licenses BioSante cancer vaccines

April 20, 2011 | By
Aduro BioTech has gained access to BioSante Pharmaceuticals' GVAX pancreas cancer vaccine and GVAX prostate cancer vaccine through a licensing agreement. The Berkeley, CA-based company plans to

Hunt for the next big cancer vaccine fraught with peril

May 6, 2010 | By
After Dendreon won a historic approval a week ago for Provenge, the world's first therapeutic cancer vaccine, a host of developers started to flag their own therapeutic vaccine programs. But in the

BioSante cancer vax promising in small study

March 11, 2010 | By
Shares of BioSante Pharmaceuticals surged this morning in pre-market trading after the developer said that a 19-patient study demonstrated the promise of its GVAX leukemia vaccine to mop up the
Related Tags
Press Releases
  • Oculus Innovative Sciences Receives FDA Clearance for Novel Atopic Dermatitis Dermatology Product
  • Augmenix Announces Publication of SpaceOAR System Clinical Trial Results in Leading Radiation Oncology Journal
  • Navidea Reports Manocept Study Results in Rheumatoid Arthritis Presented at EULAR 2015
  • Beckman Coulter Diagnostics Obtains CE Marks for New HCV RNA and HIV-1 Assays on DxN VERIS Molecular Diagnostics System
  • Medtronic Initiates U.S. Launch of Fortrex(TM) PTA Balloon
  • More Press Releases
Sponsored Links